CBGA vs CBG: Acid Precursor vs Neutral Cannabinoid
The cannabis plant makes CBGA (cannabigerolic acid) first, the raw, acidic "mother acid." Heat above roughly 100 °C strips off its acid group, a step called decarboxylation, and what remains is CBG (cannabigerol), the neutral form. The two are chemically distinct and neither is intoxicating. CBG has a characterized in-vitro receptor profile; CBGA's own pharmacology is catalogue in progress. Established
A raw, unheated extract holds its CBG-line content mostly as CBGA, and the two are different molecules with very different amounts known about them. For anyone formulating, testing or buying, the first question to ask of any "CBG" claim is which of the two the study actually used.
Grades, strongest first: the six-rung evidence ladder, with Catalogue in progress where verified evidence is lacking. Chemistry, biosynthesis, decarboxylation and intoxication status are verified; effect or benefit claims belong to others and travel with their limits. Not medical or legal advice; the full disclaimer is at the foot of the page.
At a glance
| Attribute | CBGA (cannabigerolic acid) | CBG (cannabigerol) |
|---|---|---|
| What it is | CBGA (cannabigerolic acid)The acidic precursor, or "mother acid" | CBG (cannabigerol)The neutral, decarboxylated form, or "mother cannabinoid" |
| Molecular formula | CBGA (cannabigerolic acid)C₂₂H₃₂O₄ | CBG (cannabigerol)C₂₁H₃₂O₂ |
| CAS number | CBGA (cannabigerolic acid)25555-57-1 | CBG (cannabigerol)25654-31-3 (PubChem CID 5315659) |
| Form in the plant | CBGA (cannabigerolic acid)The main acid in raw plant material | CBG (cannabigerol)A minor component that appears when CBGA is heated or the plant ages |
| Key relationship | CBGA (cannabigerolic acid)The parent acid: synthase enzymes turn it into THCA, CBDA and CBCA | CBG (cannabigerol)The neutral form of that same parent acid |
| Made by | CBGA (cannabigerolic acid)The plant's own biosynthesis | CBG (cannabigerol)Heating (decarboxylating) CBGA above ~100 °C |
| Intoxicating? | CBGA (cannabigerolic acid)No · Established | CBG (cannabigerol)No · Established |
| Own pharmacology | CBGA (cannabigerolic acid)Mostly uncharacterized · Catalogue in progress | CBG (cannabigerol)In-vitro receptor profile characterized, described in words · Demonstrated · in vitro |
| Human effect evidence | CBGA (cannabigerolic acid)No trial of isolated CBGA exists, so it is untested · Catalogue in progress | CBG (cannabigerol)Minimal: a single small trial · Low |
The six rungs, and the words each one permits
- grade: Established
- Settled science — replicated human data, or biochemistry that is not in dispute. “is shown to”
- grade: Demonstrated
- Shown reproducibly in controlled experiments — typically laboratory (in-vitro) work. “has been shown to”
- grade: Emerging
- An early signal — preclinical (animal) work, or human evidence too limited to settle the question. “may · early evidence suggests”
- grade: Low
- Limited and low-confidence — sparse, indirect, or single-source data. “limited evidence · unclear”
- grade: Hypothesized
- Proposed and plausible — but not yet shown. “proposed mechanism”
- grade: Not supported
- Tested, and the evidence does NOT support it. This is a finding against the claim — not an absence of evidence. “evidence does not support”
- Catalogue in progress
- Not a rung: our registry holds nothing graded on the question yet. Absence is not evidence against.
A grade rates the support for a claim across the literature, never a single study. How we grade evidence.
- How to read a cell
- An oxblood ring holds the direction: a bar: blocks; a chevron: activates; a chevron with a bar: activates, then desensitises; two bars: damps activation. A gold ring with a dot: recorded in a review, direction qualified by the source, no rung of its own. A dashed frame: no graded interaction in our registry.
- CB1 cannabinoid receptor
- CBGa: no graded interaction in our registry. CBG: blocks (antagonist; drawn as a bar), in vitro grade: Demonstrated study type: In vitro Cascio 2010.
- CB2 cannabinoid receptor
- CBGa: no graded interaction in our registry. CBG: no graded interaction in our registry.
- α2-adrenoceptor
- CBGa: no graded interaction in our registry. CBG: activates (agonist; drawn as a chevron), in vitro grade: Demonstrated study type: In vitro Cascio 2010.
- 5-HT1A serotonin receptor
- CBGa: no graded interaction in our registry. CBG: blocks (antagonist; drawn as a bar), in vitro grade: Demonstrated study type: In vitro Cascio 2010.
- TRPV1 and TRPV2 ion channels
- CBGa: no graded interaction in our registry. CBG: activates, then desensitises (agonist, then desensitiser; drawn as a chevron with a bar), in vitro grade: Demonstrated study type: In vitro De Petrocellis 2011.
- TRPM8 ion channel
- CBGa: no graded interaction in our registry. CBG: blocks (antagonist; drawn as a bar), in vitro grade: Demonstrated study type: In vitro De Petrocellis 2011.
From acid to neutral: what decarboxylation does
Think of CBGA and CBG as one lineage in two chemical states. CBGA carries a carboxylic-acid group; heat drives that group off as carbon dioxide, a reaction called decarboxylation, and neutral CBG is what's left. The reaction starts above roughly 100 °C, and processors typically run it at around 110–130 °C. Push the heat harder and conversion speeds up, at the risk of degrading the product. So unheated products keep their CBGA, heated or "activated" ones contain CBG, and on a COA the split between the two largely reflects how much heat and age the material has seen. Established
Mother acid vs mother cannabinoid
- CBGA is the "mother acid." The plant builds CBGA first, then dedicated synthase enzymes turn it into THCA, CBDA and CBCA, the acids that heat later converts into THC, CBD and CBC. Sitting upstream of every one of those branches makes CBGA the biosynthetic parent. Demonstrated · plant biochemistry
- CBG is the "mother cannabinoid." It is CBGA's neutral, decarboxylated form, and it inherits the "mother" label from the same lineage, as the neutral version of the plant's common starting point. Established
The nicknames are easy to confuse. "Mother acid" is the branch point itself, the raw biochemical origin. "Mother cannabinoid" is what that branch point becomes under heat.
What's actually established
The chemistry of this pair is settled. What either molecule does in a person is a much shorter story.
- Chemical identity and the acid-to-neutral link. CBGA (C₂₂H₃₂O₄, CAS 25555-57-1) is the carboxylic-acid precursor; CBG (C₂₁H₃₂O₂, CAS 25654-31-3, PubChem CID 5315659) is the neutral form it becomes on decarboxylation. Established
- Decarboxylation. Heat above ~100 °C, in practice ~110–130 °C, drives CO₂ off CBGA and leaves CBG. Established
- Biosynthetic role. The synthase route from CBGA, the shared parent acid, to THCA, CBDA and CBCA is well-characterized plant biochemistry. Demonstrated · plant biochemistry
- Neither is intoxicating. Raw or heated, neither one produces a THC-style high. Established
- CBG's in-vitro receptor profile, described in words. Lab studies show CBG acting as an α₂-adrenoceptor agonist, a 5-HT₁A (serotonin) antagonist and a CB₁ antagonist (Cascio 2010), with activity at several TRP ion channels as well (De Petrocellis 2011). Because α₂-adrenoceptors help regulate blood pressure, anyone taking cardiovascular medication should be cautious and consult a clinician. Demonstrated · in vitro
- CBG's other preclinical signals. Appendino 2008 found antibacterial activity in the lab, and Borrelli 2013 found anti-inflammatory activity in a mouse model of colitis. Both are preclinical lab or animal results, and neither is an established use in humans. Emerging
- Isolated CBGA in the body is still largely a blank. Its own pharmacology remains uncharacterized. Catalogue in progress
- Human evidence on effects or benefits is minimal for both. No demonstrated human health benefit backs a specific claim for CBGA or for CBG, so neither supports a benefit claim on a label. Low
Common questions
What's the difference between CBGA and CBG?
CBGA is the acid the plant makes; CBG is the neutral molecule left once heat removes the acid group. The core structure is shared, and the difference is that carboxylic-acid group, which CBGA (cannabigerolic acid) carries and CBG (cannabigerol) has lost. Neither is intoxicating, and they behave as distinct compounds. Established
Is CBGA just "raw CBG"?
Loosely, yes, as long as you remember they are two different molecules. CBGA is the unheated acid form, and heat turns it into CBG. CBGA also carries an extra carboxylic-acid group and has chemistry of its own, most of it uncharacterized. "Raw CBG" captures the relationship and hides the chemistry. Established
What is decarboxylation, and at what temperature does CBGA become CBG?
Decarboxylation is a heat-driven reaction that strips a carboxylic-acid group off as carbon dioxide. CBGA starts converting to neutral CBG above roughly 100 °C, and the process is typically run at around 110–130 °C. Hotter, faster heating risks degrading the product, which is why processors keep the heat gentle. Established
Why is CBGA the "mother acid" and CBG the "mother cannabinoid"?
Because CBGA comes first and CBG is its heated form. The plant makes CBGA and then converts it into THCA, CBDA and CBCA, the acids behind THC, CBD and CBC, and that upstream position earns it the biosynthetic "mother acid" title. CBG, the neutral, decarboxylated form of CBGA, carries the "mother cannabinoid" name for the same lineage. Demonstrated · plant biochemistry
Does CBGA or CBG get you high?
No; neither one intoxicates. CBGA is a non-intoxicating raw acid, and CBG, the neutral form heat produces from it, is non-intoxicating too. In lab studies CBG blocks the CB₁ receptor, where THC activates it. Staying sober is a different thing from doing good, though, and benefit has not been established for either compound. Established
Is CBGA or CBG "better"?
The evidence crowns neither; they are different forms suited to different products. CBGA is the raw precursor in unheated products, and CBG is the heated, activated form with a characterized in-vitro receptor profile. Neither has a demonstrated human health benefit, and no study has compared the two head-to-head in people, which leaves "better" an untested question rather than a refuted one. In practice the choice is raw versus activated. Not medical advice. Catalogue in progress
Informational only — not our claims, and not advice. The statements on this page about potential effects, benefits, or uses reflect claims made by third parties (manufacturers, media, traditional use, or preliminary research) and are presented for educational and informational purposes only. CBG Atlas does not make, adopt, endorse, or affirm these claims, and does not represent them as fact. These statements have not been evaluated by the Food and Drug Administration (or any regulator) and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is medical, legal, or professional advice; cannabinoid effects, safety, and legal status vary by person, product, and jurisdiction and can change over time. Consult a qualified professional before making any health or purchasing decision. Where we can, we show how strong the evidence is and cite the source; where evidence is thin or absent, we say so. Peregrine Biopharma funds the platform and holds no editorial authority.
Before you act on what you have read
Informational only, not medical advice. CBG Atlas is a scientific reference. Nothing here diagnoses, treats, cures or prevents any disease. Every claim on the page carries the grade of the evidence behind it, and the grade sets the words the claim may use. How we grade evidence.
Each grade rates the support for a claim across the literature. It does not rate any single study. An effect in cells may never show up in people. The grades cover the studies checked up to 9 August 2026. This page is for information and is not medical advice.
Cardiovascular note. CBG is a potent α2-adrenoceptor agonist in vitro, and α2 agonism can lower blood pressure. Anyone taking blood-pressure or other cardiovascular medication should consult a clinician before use. This is educational information, not medical advice.
Funding and independence. Peregrine Biopharma funds the platform and holds no editorial authority.
Report a safety event →Keep exploring
The compounds compared
More comparisons